Literature DB >> 20559801

Postoperative deep infection in tumor endoprosthesis reconstruction around the knee.

Takeshi Morii1, Hiroo Yabe, Hideo Morioka, Yasuo Beppu, Hirokazu Chuman, Akira Kawai, Ken Takeda, Kazutaka Kikuta, Seiichi Hosaka, Yasuo Yazawa, Katsuhito Takeuchi, Ukei Anazawa, Kazuo Mochizuki, Kazuhiko Satomi.   

Abstract

BACKGROUND: Although deep infection remains one of the most difficult complications to manage in the treatment of musculoskeletal tumor reconstructed with an endoprosthesis, limited information with respect to its incidence and risk factors has been reported.
METHODS: This multicenter, retrospective, uncontrolled study reviewed the medical records of 82 patients who underwent reconstruction with an endoprosthesis or temporary spacer for bone-immature patients after resection of malignant bone tumor around the knee. Risk factors for deep infection and the impact of deep infection on prosthesis survival and oncological outcomes were analyzed. Deep infection was defined according to the Centers for Disease Control and Prevention (CDC) guidelines with minor modification.
RESULTS: Deep infection occurred in 14 cases (17%), identified at a mean of 10.9 months (range <1 to 48 months) after initial surgery. Univariate analysis identified surface infection (P < 0.001) and skin necrosis (P < 0.001) as risk factors associated with deep infection. Conversely, tumor origin, chemotherapy, number of postoperative antibiotics, and length of bone resection were not associated with infection. Subclass analysis in femur cases identified a correlation between infection and the extent of partial resection of the quadriceps muscle (P = 0.04). In the multivariate analysis, surface infection represented an independent risk factor for deep infection (P = 0.03). Deep infection was a risk for endoprosthesis survival (P = 0.003) but did not affect the oncological outcome.
CONCLUSIONS: A strong correlation between the condition of soft tissue and establishment of deep infection is suggested in this study. Although practical options for preventing deep infection seem limited, the present data allow a form of perioperative evaluation for patients with a higher risk of deep infection.

Entities:  

Mesh:

Year:  2010        PMID: 20559801     DOI: 10.1007/s00776-010-1467-z

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  11 in total

Review 1.  [Risk factors and management strategies for early and late infections following reconstruction with special tumour endoprostheses].

Authors:  V Janz; J Löchel; A Trampuz; K-D Schaser; A Hofer; G I Wassilew
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

2.  Treatment solutions are unclear for perimegaprosthetic infections.

Authors:  Lisa B Ercolano; Tyson Christensen; Richard McGough; Kurt Weiss
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

Review 3.  High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review.

Authors:  Antonella Racano; Theresa Pazionis; Forough Farrokhyar; Benjamin Deheshi; Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2013-02-12       Impact factor: 4.176

4.  Prophylactic antibiotic regimens in tumor surgery (PARITY) survey.

Authors:  Khaled Hasan; Antonella Racano; Benjamin Deheshi; Forough Farrokhyar; Jay Wunder; Peter Ferguson; Ginger Holt; Herbert Schwartz; Brad Petrisor; Mohit Bhandari; Michelle Ghert
Journal:  BMC Musculoskelet Disord       Date:  2012-06-07       Impact factor: 2.362

5.  Modular Endoprostheses for Nonneoplastic Conditions: Midterm Complications and Survival.

Authors:  Marco De Gori; Guido Scoccianti; Filippo Frenos; Leonardo Bettini; Filippo Familiari; Giorgio Gasparini; Giovanni Beltrami; Pierluigi Cuomo; Pietro De Biase; Rodolfo Capanna
Journal:  Biomed Res Int       Date:  2016-12-05       Impact factor: 3.411

6.  Imaging of Complications After Limb Prostheses Implantation in Children with Bone Tumors.

Authors:  Beata Iwanowska; Hanna Brągoszewska; Jarosław Mądzik; Sylwia Szkudlińska-Pawlak; Izabela Kopyś-Wiszniewska; Małgorzata Jastrzębska; Barbara Kowalska; Maria Uliasz; Monika Bekiesińska-Figatowska
Journal:  Pol J Radiol       Date:  2017-04-22

7.  Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study.

Authors:  Michelle Ghert; Benjamin Deheshi; Ginger Holt; R Lor Randall; Peter Ferguson; Jay Wunder; Robert Turcotte; Joel Werier; Paul Clarkson; Timothy Damron; Joseph Benevenia; Megan Anderson; Mark Gebhardt; Marc Isler; Sophie Mottard; John Healey; Nathan Evaniew; Antonella Racano; Sheila Sprague; Marilyn Swinton; Dianne Bryant; Lehana Thabane; Gordon Guyatt; Mohit Bhandari
Journal:  BMJ Open       Date:  2012-11-28       Impact factor: 2.692

8.  Deep infection in tumor endoprosthesis around the knee: a multi-institutional study by the Japanese musculoskeletal oncology group.

Authors:  Takeshi Morii; Hideo Morioka; Takafumi Ueda; Nobuhito Araki; Nobuyuki Hashimoto; Akira Kawai; Kazuo Mochizuki; Shoichi Ichimura
Journal:  BMC Musculoskelet Disord       Date:  2013-01-31       Impact factor: 2.362

9.  Surgical management of appendicular skeletal metastases in thyroid carcinoma.

Authors:  Robert L Satcher; Patrick Lin; Nursat Harun; Lei Feng; Bryan S Moon; Valerae O Lewis
Journal:  Int J Surg Oncol       Date:  2012-12-12

10.  The inter-rater reliability of the diagnosis of surgical site infection in the context of a clinical trial.

Authors:  J Nuttall; N Evaniew; P Thornley; A Griffin; B Deheshi; T O'Shea; J Wunder; P Ferguson; R L Randall; R Turcotte; P Schneider; P McKay; M Bhandari; M Ghert
Journal:  Bone Joint Res       Date:  2016-08       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.